216 related articles for article (PubMed ID: 30458003)
21. Serological cancer-associated protein biomarker levels at bowel endoscopy: Increased risk of subsequent primary malignancy.
Piper TB; Nielsen HJ; Christensen IJ
Tumour Biol; 2022; 44(1):1-16. PubMed ID: 35180141
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis.
Jin WJ; Xu JM; Xu WL; Gu DH; Li PW
World J Gastroenterol; 2014 Nov; 20(43):16334-42. PubMed ID: 25473192
[TBL] [Abstract][Full Text] [Related]
23. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
24. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic value of circular RNAs in colorectal cancer: A systematic review and meta-analysis.
Zhao Z; Zhao Y; Liu Y; Zou J; Zhu Y
Pathol Res Pract; 2019 Dec; 215(12):152680. PubMed ID: 31635986
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies.
Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y
Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic role of circulating MiR-21 in colorectal cancer: a update meta-analysis.
Liu T; Liu D; Guan S; Dong M
Ann Med; 2021 Dec; 53(1):87-102. PubMed ID: 33108223
[TBL] [Abstract][Full Text] [Related]
28. Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.
Bastaminejad S; Taherikalani M; Ghanbari R; Akbari A; Shabab N; Saidijam M
Iran Biomed J; 2017 Mar; 21(2):106-13. PubMed ID: 27432735
[TBL] [Abstract][Full Text] [Related]
29. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis.
Yang X; Zeng Z; Hou Y; Yuan T; Gao C; Jia W; Yi X; Liu M
PLoS One; 2014; 9(2):e88745. PubMed ID: 24551148
[TBL] [Abstract][Full Text] [Related]
31. Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.
Waas ET; Wobbes T; Ruers T; Lomme RM; Hendriks T
Eur J Surg Oncol; 2006 Sep; 32(7):756-63. PubMed ID: 16650961
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis.
Sun G; Meng J; Duan H; Zhang D; Tang Y
Pathol Oncol Res; 2019 Oct; 25(4):1525-1534. PubMed ID: 30488278
[TBL] [Abstract][Full Text] [Related]
33. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
34. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
35. TIMP-1 and CEA as biomarkers in third-line treatment with irinotecan and cetuximab for metastatic colorectal cancer.
Spindler KL; Christensen IJ; Nielsen HJ; Jakobsen A; Brünner N
Tumour Biol; 2015 Jun; 36(6):4301-8. PubMed ID: 25608838
[TBL] [Abstract][Full Text] [Related]
36. Circulating microRNA-21 as a potential diagnostic marker for colorectal cancer: A meta-analysis.
Yu W; Wang Z; Shen LI; Wei Q
Mol Clin Oncol; 2016 Feb; 4(2):237-244. PubMed ID: 26893868
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer.
Xu J; Ye Y; Zhang H; Szmitkowski M; Mäkinen MJ; Li P; Xia D; Yang J; Wu Y; Wu H
Medicine (Baltimore); 2016 Jan; 95(2):e2502. PubMed ID: 26765465
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
[TBL] [Abstract][Full Text] [Related]
39. Serum piRNA-54265 is a New Biomarker for early detection and clinical surveillance of Human Colorectal Cancer.
Mai D; Zheng Y; Guo H; Ding P; Bai R; Li M; Ye Y; Zhang J; Huang X; Liu D; Sui Q; Pan L; Su J; Deng J; Wu G; Li R; Deng S; Bai Y; Ligu Y; Tan W; Wu C; Wu T; Zheng J; Lin D
Theranostics; 2020; 10(19):8468-8478. PubMed ID: 32754257
[No Abstract] [Full Text] [Related]
40. Diagnostic value of fecal tumor M2-pyruvate kinase for CRC screening: a systematic review and meta-analysis.
Li R; Liu J; Xue H; Huang G
Int J Cancer; 2012 Oct; 131(8):1837-45. PubMed ID: 22261915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]